Literature DB >> 17342339

Molecular analyses and prognostic relevance of HPV in head and neck tumours.

Gianna Badaracco1, Consuelo Rizzo, Barbara Mafera, Barbara Pichi, Diana Giannarelli, Siavash S Rahimi, Maurizio G Vigili, Aldo Venuti.   

Abstract

HPV involvement in head and neck (HN) cancer is still under active investigation. Fresh frozen and archival clinical samples from 115 patients affected by HN carcinomas were analysed by PCR-based methods and direct sequencing. HPV types, intra-type variants, physical status, viral load and viral transcript presence were determined. HPV positivity was correlated with the main clinical-pathological features, including smoker and drinker status, and the clinical outcome. Twenty-one tumours were HPV positive (18.3%) with HPV16 being the most frequent type (n=14) followed by HPV6 (n=4), HPV33, HPV35, and HPV58 (n=1, each type). Tonsil carcinomas contained more high-risk HPV types (6/8; 75%) than all other sites (p=0.0004). HPV16 genome was integrated in all analysed tumours, as pure integrated form or mixed with concomitant episomal forms (4 cases). The viral load showed a wide variability (range, 0.7-485 copies per cell) with the highest value detected in a larynx tumour and the lowest one in a case of cancer of the oral cavity. In 9 HPV-positive samples where mRNA was available, transcripts of viral early oncogenes originating by integrated, episomal or mixed forms of the viral genome were found. A statistically significant correlation was evidenced between HPV and tumour differentiation, being the virus more associated with tumour grade G3/G4. Multivariate Cox regression analysis revealed that lymph-node and grade status were significant independent factors for a worse disease-free survival and overall survival, whereas the HPV status was associated with a better overall survival (OR, 0.33; 95% CI, 0.13-0.81; p=0.01). Taken together these results indicate that distinct pathological mechanisms for the malignant transformation in each single HN subsite should be taken in account; HPV molecular analyses should be considered a valid tool to distinguish subsets of oropharyngeal tumours and HPV presence could be useful for the prognostic assessment of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342339

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  21 in total

1.  Immunotherapy in new pre-clinical models of HPV-associated oral cancers.

Authors:  Francesca Paolini; Silvia Massa; Isabella Manni; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

2.  Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).

Authors:  Beth Wadsworth; Jeffery M Bumpous; Alvin W Martin; Michael R Nowacki; Alfred B Jenson; Hanan Farghaly
Journal:  Head Neck Pathol       Date:  2011-07-30

Review 3.  Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.

Authors:  Aarti Bhatia; Barbara Burtness
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

4.  The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways.

Authors:  Tatyana Isayeva; Jie Xu; Camille Ragin; Qian Dai; Tiffiny Cooper; William Carroll; Dan Dayan; Marilena Vered; Bruce Wenig; Eben Rosenthal; William Grizzle; Joshua Anderson; Christopher D Willey; Eddy S Yang; Margaret Brandwein-Gensler
Journal:  Mod Pathol       Date:  2014-12-19       Impact factor: 7.842

Review 5.  HPV detection methods in head and neck cancer.

Authors:  Aldo Venuti; Francesca Paolini
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 6.  Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.

Authors:  Tatyana Isayeva; Yufeng Li; Daniel Maswahu; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-07-03

7.  Human papillomavirus and WHO type I nasopharyngeal carcinoma.

Authors:  Emily J Lo; Diana Bell; Jason S Woo; Guojun Li; Ehab Y Hanna; Adel K El-Naggar; Erich M Sturgis
Journal:  Laryngoscope       Date:  2010-10       Impact factor: 3.325

Review 8.  Laryngeal squamous cell carcinoma in a 13 year-old child associated with human papillomaviruses 16 and 18: a case report and review of the literature.

Authors:  Beth Joos; Nathan Joos; Jeffrey Bumpous; Carolyn Burns; Christopher A French; Hanan Farghaly
Journal:  Head Neck Pathol       Date:  2008-11-22

9.  HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract.

Authors:  Paolo Boscolo-Rizzo; Maria Cristina Da Mosto; Roberto Fuson; Helena Frayle-Salamanca; Rossana Trevisan; Annarosa Del Mistro
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-08       Impact factor: 4.553

10.  Human papillomavirus genotype and oropharynx cancer survival in the United States of America.

Authors:  Marc T Goodman; Mona Saraiya; Trevor D Thompson; Martin Steinau; Brenda Y Hernandez; Charles F Lynch; Christopher W Lyu; Edward J Wilkinson; Thomas Tucker; Glenn Copeland; Edward S Peters; Sean Altekruse; Elizabeth R Unger
Journal:  Eur J Cancer       Date:  2015-11-18       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.